Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

SCNI stock hub

Scinai Immunotherapeutics Ltd. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SCNIis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

SCNI

In the news

Latest news · SCNI

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-91.9

P25 -105.6P50 -46.5P75 -3.1

ROIC-42

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SCNI market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

187

Groups with data

Currency

USD

Showing 187 of 187 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001611747
Company name	Scinai Immunotherapeutics Ltd.
Country	Israel
Country code	US
Cusip	09073Q204
Employees	31
Employees Change	-2%
Employees Change Percent	-6.06
Enterprise value	$2.6M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US09073Q3039
Last refreshed	2026-05-10
Market cap	$2M
Market cap category	Nano-Cap
Price	$0.57
Price currency	USD
Rev Per Employee	42,290.32x
Sector	Healthcare
Sic	2836
Symbol	SCNI
Website	https://www.scinai.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-421.83%
EV/Sales	1.96x
FCF yield	-307.48%
P/B ratio	0.8x
P/S ratio	1.5x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	-202.29%
Gross Profit	$-2.7M
Net Income	$-8.3M
Net Income Growth Years	0%
Pretax Margin	-633.64%
Profit Per Employee	$-267,968
ROA	-37.6
Roa5y	-30.03
ROCE	-75.11
ROE	-91.89
ROIC	-42.03

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-47.62%
Cagr1y	-79.74%
Cagr3y	-69.17%
Cagr5y	-71.19%
EPS Growth Years	0
Revenue Growth	99.24x
Revenue Growth Q	30.58x
Revenue Growth Years	1x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.1
Assets	$11.6M
Cash	$1.7M
Current Assets	$2.1M
Current Liabilities	$1.6M
Debt	$2.3M
Debt Equity	$0.28
Equity	$8.1M
Interest Coverage	-21.01
Liabilities	$3.5M
Long Term Assets	$9.6M
Long Term Liabilities	$1.9M
Net Cash	$-606,000
Net Cash By Market Cap	$-30.77
Net Debt Equity	$0.07
Tangible Book Value	$2.5M
Tangible Book Value Per Share	$0.71
WACC	14.27

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.3
Net Working Capital	$-863,000
Quick ratio	1.15
Working Capital	$469,000
Working Capital Turnover	$2.49

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-189.55%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-99.84%
1Y total return	-79.72%
200-day SMA	1.07
3Y total return	-97.07%
50-day SMA	0.66
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.8%
All Time High	6,200
All Time High Change	-99.99%
All Time High Date	2020-07-13
All Time Low	0.45
All Time Low Change	24.82%
All Time Low Date	2026-04-23
ATR	0.1
Beta	2.19
Beta1y	2.27
Beta2y	1.33
Ch YTD	-20.26
High	0.61
High52	6.18
High52 Date	2025-06-05
High52ch	-90.81%
Low	0.51
Low52	0.45
Low52 Date	2026-04-23
Low52ch	24.82%
Ma50ch	-13.43%
Premarket Change Percent	1.49
Premarket Price	$0.55
Premarket Volume	1,837
Price vs 200-day SMA	-46.84%
RSI	45.52
RSI Monthly	36.45
RSI Weekly	36.01
Sharpe ratio	-0.81x
Sortino ratio	-1.25
Total Return	-189.55%
Tr YTD	-20.26
Tr1m	-0.47%
Tr1w	-20.03%
Tr3m	-31.73%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-7.5M
Operating margin	-575.3

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,052,246%
Float Percent	88.01%
Shares Insiders	11.99%
Shares Institutions	5.21%
Shares Out	3,468,224
Shares Qo Q	0%
Shares Yo Y	189.55%
Short Float	2.39%
Short Ratio	1.41
Short Shares	2.1

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-6.4M
Average Volume	10,308,533.25x
Bv Per Share	0.71
CAPEX	$-24,000
Ch10y	-99.84
Ch1m	-0.47
Ch1w	-20.03
Ch1y	-79.72
Ch3m	-31.73
Ch3y	-97.07
Ch5y	-99.8
Ch6m	-44.33
Change	4.49%
Change From Open	2.25
Close	0.54
Days Gap	2.19
Depreciation Amortization	1,421,000
Dollar Volume	114,448
Earnings Date	2026-05-11
Earnings Time	amc
EBIT	$-7.5M
EBITDA	$-6.1M
EPS	$-3.56
F Score	2
FCF	$-6.1M
FCF EV Yield	-235.12x
FCF Per Share	$-1.75
Financing CF	5,770,000
Fiscal Year End	December
Founded	2,003
Investing CF	-24,000
Is Primary Listing	0
Is Spac	No
Last Earnings Date	2026-04-01
Last Report Date	2025-12-31
Last Split Date	2024-05-21
Last Split Type	Reverse
Last10k Filing Date	2026-04-01
Ma150	0.9
Ma150ch	-37.18%
Ma20	0.6
Ma20ch	-6.06%
Net CF	-284,000
Next Earnings Date	2026-05-22
Open	0.56
Optionable	No
Position In Range	58.05
Post Close	0.57
Postmarket Change Percent	-0.93
Postmarket Price	$0.56
Ppne	9,572,000
Pre Close	0.54
Price Date	2026-05-08
Ptbv Ratio	0.8
Relative Volume	0.02x
Revenue	1,311,000x
SBC By Revenue	23.11x
Share Based Comp	303,000
Tr6m	-44.33%
Volume	201,564
Z Score	-16.64

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does SCNI pay a dividend?

Capital-return profile for this ticker.

Performance

SCNI stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SCNI?

Insider, institutional, and short-interest positioning.

Institutional ownership

+5.2%

Float: +88.0% of shares outstanding

Insider ownership

+12.0%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

SCNI momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

45.5

Neutral momentum band

Price vs 200-day MA

-46.8%

50/200-day relationship not available

Beta (5Y)

2.19

More volatile than the market

Sharpe ratio

-0.81

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SCNI

Hub-level FAQ points readers to the deeper analysis pages.

What is the current SCNI stock rating?

Scinai Immunotherapeutics Ltd. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full SCNI analysis?

The full report lives at /stocks/SCNI/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for SCNI?

The latest report frames SCNI around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the SCNI page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.